These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 4222908)

  • 1. [Diazoxide experimentally exercises an inhibitory action on the basal secretion of insulin].
    Loubatières A; Alric R; Mariani MM; de Malbosc H; Ribes G
    C R Seances Soc Biol Fil; 1966; 160(1):168-71. PubMed ID: 4222908
    [No Abstract]   [Full Text] [Related]  

  • 2. [Demonstration of the direct inhibitory action of diazoxide on insulin secretion by the pancreas].
    Loubatières A; Alric R; Mariani MM
    C R Acad Hebd Seances Acad Sci D; 1966 May; 262(19):2096-8. PubMed ID: 4957238
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of diazoxide on insulin secretion studied by biological and immunological methods of determination].
    Loubatières A; Mariani MM; Alric R; Chapal J
    C R Seances Soc Biol Fil; 1966; 160(8):1635-8. PubMed ID: 4227882
    [No Abstract]   [Full Text] [Related]  

  • 4. Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage.
    Guo Z; Bu S; Yu Y; Ghatnekar G; Wang M; Chen L; Bu M; Yang L; Zhu B; Feng Z; Huang Q
    J Diabetes Complications; 2008; 22(1):46-55. PubMed ID: 18191077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diazoxide on insulin secretion in vitro.
    Howell SL; Taylor KW
    Lancet; 1966 Jan; 1(7429):128-9. PubMed ID: 4158956
    [No Abstract]   [Full Text] [Related]  

  • 6. Galanin inhibits caerulein-stimulated pancreatic amylase secretion via cholinergic nerves and insulin.
    Barreto SG; Woods CM; Carati CJ; Schloithe AC; Jaya SR; Toouli J; Saccone GT
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G333-9. PubMed ID: 19497960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Participation of insulin in diazoxide hyperglycemia].
    Losert W; Senft G; Sitt R; Schultz G; Kaess H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(3):388-94. PubMed ID: 4223206
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the inhibitory action of diazoxide on the insulin secretion of the isolated and perfused rat pancreas: non-involvement of the alpha adrenergic receptors].
    Mariani MM; Loubatières A; Chapal J
    C R Seances Soc Biol Fil; 1971; 165(6):1398-401. PubMed ID: 4262052
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of an antihypertensive agent on the biliary and external pancreatic secretions of the rat].
    Debray C; Vaille C; De la Tour J; Roze C; Souchard M
    Rev Int Hepatol; 1969; 19(6):425-37. PubMed ID: 5365740
    [No Abstract]   [Full Text] [Related]  

  • 10. Galanin potentiates supramaximal caerulein-stimulated pancreatic amylase secretion via its action on somatostatin secretion.
    Barreto SG; Carati CJ; Schloithe AC; Toouli J; Saccone GT
    Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1268-73. PubMed ID: 19779018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study of a hyperglycemic sulfonamide, diazoxide].
    Loubatières A; Mariani MM; Ribes G; De Malbosc H
    C R Seances Soc Biol Fil; 1966; 160(1):165-8. PubMed ID: 4222907
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pancreas exocrine and glycemia modification. I. Action of diazoxide, alone and in the presence of sodium bicarbonate, on pancreas and biliary secretion in rats].
    Debray C; de La Tour J; Vaille C; Roze C; Souchard M
    Therapie; 1968; 23(3):649-62. PubMed ID: 5740627
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of Cicletanine, a new antihypertensive agent on insulin release in rat isolated pancreas by the perfusion technique.
    Mashori GR; Tariq AR; Shahimi MM; Suhaimi H
    Singapore Med J; 1996 Jun; 37(3):278-81. PubMed ID: 8942229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro effect of catecholamines, diazoxide and theophylline on insulin release.
    Wong KK; Symchowicz S; Staub MS; Tabachnick II
    Life Sci; 1967 Nov; 6(21):2285-91. PubMed ID: 6060274
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on the metabolic effects of diazoxide.
    Tabachnick II; Gulbenkian A; Seidman F
    J Pharmacol Exp Ther; 1965 Dec; 150(3):455-62. PubMed ID: 5852879
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of hydrochlorthiazide on the blood sugar-increasing action of diazoxide].
    Sitt R; Senft G; Losert W; Kaess H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(3):402-8. PubMed ID: 4223208
    [No Abstract]   [Full Text] [Related]  

  • 17. Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man.
    Fajans SS; Floyd JC; Knopf RF; Rull J; Guntsche EM; Conn JW
    J Clin Invest; 1966 Apr; 45(4):481-92. PubMed ID: 4287058
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of the mechanisms implicated in the hyperglycemic action of diazoxide].
    Loubatières A; Mariani MM; Alric R
    C R Acad Hebd Seances Acad Sci D; 1966 Apr; 262(16):1792-5. PubMed ID: 4956486
    [No Abstract]   [Full Text] [Related]  

  • 19. Some effects of the hypotensive drug diazoxide on the cardiovascular system.
    Nayler WG; McInnes I; Swann JB; Race D; Carson V; Lowe TE
    Am Heart J; 1968 Feb; 75(2):223-32. PubMed ID: 4951320
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological and immunological determinations of insulin demonstrating that diazoxide checks insulin secretion].
    Loubatières A; Mariani MM; Alric R; Chapal J
    C R Acad Hebd Seances Acad Sci D; 1966 Aug; 263(8):687-90. PubMed ID: 4961590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.